Greg Mader is a Principal within our Market Access Practice. Greg is a seasoned HEOR and market access professional with extensive experience partnering with clients in small biotech and large pharmaceutical companies. His engagements have spanned across a wide variety of therapeutic areas, including neuroscience, gastroenterology, ophthalmology, nephrology, cardiovascular, oncology, hematology, women’s health, and gene therapies. He holds a Ph.D. in Biomathematics from North Carolina State University. Prior to joining Herspiegel, Greg held positions of increasing responsibility at RTI Health Solutions and Aesara.